GENERATIVE ANTIBODY
Live / Applied — Extension of time to oppose received (as of 04 Aug 2026)
What this means for you
Not registered yet, but its 24 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99513871
- Mark type
- Word mark
- Filed
- 24 Nov 2025
- Published for opposition
- 07 Jul 2026
Goods and services
- Class 042 — Scientific and technological services: Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data exploration; Platform as a service (PAAS) featuring computer software platforms for for use in artificial intelligence.; Software as a service (SAAS) services featuring software for use in database management; Research in the field of bioinformatics
Owner
- Generatixe Inc., San Diego, CA, US
- Generatixe Inc., San Diego, CA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 99513871 — Generate Biomedicines, Inc. v. Generatixe Inc., filed 04 Aug 2026 (Open)
Prosecution history
- 04 Aug 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Apr 2026 — NON-FINAL ACTION E-MAILED
- 14 Apr 2026 — NON-FINAL ACTION WRITTEN
- 30 Mar 2026 — ASSIGNED TO EXAMINER
- 24 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Nov 2025 — NEW APPLICATION ENTERED